Advocacy Alert: Statement from SAMHSA Leader on FDA’s Drug Safety Alert on Buprenorphine and Risk for Tooth Decay

Advocacy Alert: December 2021 Legislative News Round Up

Jan 6, 2022 | Advocacy Alert

    Advocacy Advocacy Alerts Find Your Representatives State FAQs Legal Repository Contact Us Advocacy Alert: December 2021 Legislative News Round Up January 6, 2022 For those of you who follow us on social media know, we post news stories on a daily basis that are...
Advocacy Alert: Statement from SAMHSA Leader on FDA’s Drug Safety Alert on Buprenorphine and Risk for Tooth Decay

Advocacy Alert: 2021 Year End Advocacy Update

Dec 23, 2021 | Advocacy Alert

Advocacy Advocacy Alerts Find Your Representatives State FAQs Legal Repository Contact Us Advocacy Alert: 2021 Year End Advocacy Update December 23, 2021 Did you know that one of the many benefits BHAP members get is regular access to our advocate in Washington, DC,...